The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India over the weekend, according to government sources. "We have received the data from the phase III trials," a senior government official confirmed. The phase III data of its vaccine have been questioned various times and that …
